A diverse and well-trained scientific workforce is necessary to advance biomedical research, improve human health and to develop effective remedies for disease. The University of Missouri-Columbia (MU) is the only four-year comprehensive public university in the State of Missouri and has a critical role in training the next generation of scientists. As part of the University of Missouri-Columbia (MU) commitment to scientific training and diversity, and with prior funding from NIH, we have developed a successful and innovative program to prepare underrepresented minority students for biomedical research. We have three objectives for our Initiative to Maximize Student Diversity (IMSD) program. First, to further develop a supportive and engaged peer community of minority undergraduate students that are interested in exploring biomedical research. We will increase the number of MU freshmen/sophomore students who are exploring a career in biomedical research. Second, we will expand a program targeted at MU junior/senior students that involves these advanced undergraduates in independent research experiences and prepares them for graduate study in the biomedical sciences. Third, we will provide a structured and mentored research environment for minority graduate students to develop into independent scientists as they pursue their PhD degree in a biomedical discipline. Further development of our IMSD program will have a substantial impact on diversity at the University and on our nation's scientific workforce.
A robust biomedical research enterprise is required to improve human health and reduce morbidity and mortality from disease. A diverse scientific workforce, which utilizes the talents and skills of all individuals, is a necessary component of a robust research enterprise. The goal of our program is to increase the diversity of PhD scientists trained in biomedical research.
|Swatek, Kirby N; Wilson, Rashaun S; Ahsan, Nagib et al. (2014) Multisite phosphorylation of 14-3-3 proteins by calcium-dependent protein kinases. Biochem J 459:15-25|
|Morgan, Brandie R; Coates, Joan R; Johnson, Gayle C et al. (2014) Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis. J Neurosci Res 92:531-41|
|Ahsan, Nagib; Huang, Yadong; Tovar-Mendez, Alejandro et al. (2013) A versatile mass spectrometry-based method to both identify kinase client-relationships and characterize signaling network topology. J Proteome Res 12:937-48|
|Buckley, Desire M; Burroughs-Garcia, Jessica; Lewandoski, Mark et al. (2013) Characterization of the Gbx1-/- mouse mutant: a requirement for Gbx1 in normal locomotion and sensorimotor circuit development. PLoS One 8:e56214|
|Alexander, Stephen; Swatson, William S; Alexander, Hannah (2013) Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism. Methods Mol Biol 983:185-204|
|Dale, J M; Villalon, E; Shannon, S G et al. (2012) Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E. Genes Brain Behav 11:360-5|
|Swatek, Kirby N; Graham, Katherine; Agrawal, Ganesh K et al. (2011) The 14-3-3 isoforms chi and epsilon differentially bind client proteins from developing Arabidopsis seed. J Proteome Res 10:4076-87|
|Cain, Charlette; Phillips, Thomas E (2008) Developmental changes in conjunctiva-associated lymphoid tissue of the rabbit. Invest Ophthalmol Vis Sci 49:644-9|
|LaCrue, Alexis N; Sivaguru, Mayandi; Walter, Marika F et al. (2006) A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites. Mol Biochem Parasitol 148:199-209|
|Lacrue, Alexis N; James, Anthony A; Beerntsen, Brenda T (2005) The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites. Am J Trop Med Hyg 73:634-43|
Showing the most recent 10 out of 14 publications